Managing AEs Seen with Bispecifics
Medical experts discuss how adverse events vary by bispecific class, the specific adverse events observed in practice, and their management strategies.
EP: 1.Importance of Collaboration between Academic and Community Centers
EP: 2.Referral Process: Streamlining and Challenges Seen
EP: 3.Referral Process: Bispecifics
EP: 4.Similarities and Differences among Bispecifics: BCMA vs non-BCMA
EP: 5.Types of Referrals and Impact of Social Factors on the Referral Process
Now Viewing
EP: 6.Managing AEs Seen with Bispecifics
EP: 7.Referral Process: CAR T-Cell Therapy
EP: 8.CAR T: Impact of Recent Approvals on the Referral Process
EP: 9.Long-Term Monitoring of AEs and Reintegrating Patients back into Community Care
EP: 10.Clinical Pearls about the Referral Process of Bispecifics and CAR-T in RRMM
Video content above is prompted by the following:
- How do the adverse events (AEs) differ based on the class of bispecific? Which AEs are you seeing in practice?
- How are they managed?
Recent Videos
Related Content
